Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

June 11, 2025

New Releases from NCBI BookshelfComparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].Comparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].

Leave a Comment / Uncategorized / admin

Myasthenia gravis (MG) is an autoimmune neuromuscular disease caused by autoantibodies directed at the neuromuscular junction. The estimated prevalence is […]

New Releases from NCBI BookshelfNivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence.Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfComparing Online and In-Person Family Therapy for Teens with Traumatic Brain Injury and Their Parents [Internet].Comparing Online and In-Person Family Therapy for Teens with Traumatic Brain Injury and Their Parents [Internet].

Leave a Comment / Uncategorized / admin

Traumatic brain injury (TBI) in children contributes to significant morbidity and family burden. Persistent behavioral problems are common, yet many

New Releases from NCBI BookshelfDuvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) .Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) .

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAsciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors.Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfImlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease.Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAlpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer.Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAbemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence.Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfComparing Two Programs to Maintain Weight Loss among Black Women with Obesity [Internet].Comparing Two Programs to Maintain Weight Loss among Black Women with Obesity [Internet].

Leave a Comment / Uncategorized / admin

Black women have the highest prevalence of obesity (56.6%) in the United States. The US Preventive Services Task Force recommends

New Releases from NCBI BookshelfGuselkumab for treating active psoriatic arthritis after inadequate response to DMARDs.Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs.

Leave a Comment / Uncategorized / admin

Post Content

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top